Desferrioxamine, an iron chelator, enhances HIF-1α accumulation via cyclooxygenase-2 signaling pathway
- 1 April 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 343 (1) , 8-14
- https://doi.org/10.1016/j.bbrc.2006.02.116
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancerLung Cancer, 2003
- Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinomaCancer, 2003
- Why there are two cyclooxygenase isozymesJournal of Clinical Investigation, 2001
- The role of cyclooxygenases in inflammation, cancer, and developmentOncogene, 1999
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- Microenvironmental control of gene expression: Implications for tumor angiogenesis, progression, and metastasisSeminars in Radiation Oncology, 1998
- Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viabilityBritish Journal of Cancer, 1998
- Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulationBiochemical Journal, 1996
- Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells.Proceedings of the National Academy of Sciences, 1996
- Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesisBlood, 1990